• What We Do
  • Who We Are
  • Simulations
  • Presentations & Research
  • Contact Us
  • White Paper
  • Disclaimer
  • Industry Sector
  • Global Region
  • ETF's and Futures
  • Major Funds - Holding
  • Tutorial
  • Best Risk Adjusted
  • Worst Risk Adjusted
  • Best Expected
  • Worst Expected
  • Sector Ranking
  • Dividend
  • REIT's
  • Leverage Risk
  • Convertible Bonds
  • Investment Grade
  • High Yield
  • ADR
  • Small Caps
Rational Investing
  • About Usarrow_drop_down
  • Coveragearrow_drop_down
  • Returnsarrow_drop_down
  • Productarrow_drop_down


Diagnostic Substances

       Total Market Capitalization of All Firms $83,048 mm             
       Average Market Capitalization $13,841 mm       
       Average Market to Model Ratio Weighted by Log of Market Cap 1.1       
       Standard Deviation of MM Ratio 0.4       
       Average Beta 0.9       
       Average EV To Revenue 6.9       
       Average EV To EBITDAM 28.0       
       Average Price To Free Cash Flow 40.3       

TickerCompany NameMarket To ModelMarket Cap ($ mm)EV to RevenuePrice To FCFEV/EBITDAM% GrowthBetaAs Of
IDXXIdexx Laboratories Inc.1.4931,69012.869.047.260.9Jun 20
NEOGNeogen Corp.1.313,8349.060.946.220.7May 20
IQVIQVIA Holdings Inc1.1529,2053.835.724.7-31.3Jun 20
ICLRIcon Plc1.149,6623.637.723.6-21.0Jun 20
VIVOMeridian Bioscience Inc.0.626611.88.45.01060.7Jun 20
QDELQuidel Corp.0.537,99510.530.121.2431.0Jun 20
Standard Value | About us | Contact us     Copyright © 2003-2020 Rational Investing LLC ® | All Rights Reserved